Hyponatremia in cirrhosis and end-stage liver disease: treatment with the vasopressin V₂-receptor antagonist tolvaptan.
about
Usefulness of portal vein pressure for predicting the effects of tolvaptan in cirrhotic patientsDo vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?Increase in hypotonic stress-induced endocytic activity in macrophages via ClC-3.Clinical efficacy of tolvaptan for treatment of refractory ascites in liver cirrhosis patientsRelationship and interaction between serum sodium concentration and portal hemodynamics in patients with cirrhosis.Role of albumin in cirrhosis: from a hospitalist's perspective.Systemic vascular resistance and fluid status in patients with decompensated liver cirrhosis with or without functional renal failure in Egypt.Defining the role of albumin infusion in cirrhosis-associated hyponatremia.Is Exaggerated Release of Arginine Vasopressin an Endocrine Disorder? Pathophysiology and Treatment.Urinary excretion of the water channel aquaporin 2 correlated with the pharmacological effect of tolvaptan in cirrhotic patients with ascites.
P2860
Q24658600-76E5EAD0-517C-4055-9E95-CC00C454F255Q26778032-74EC5B9C-6954-46DD-9142-BE92ACCE80B7Q33707990-7886BC0A-072E-4EB4-917C-C9AE7B386312Q34093932-683DD9C8-9DD1-4D2E-8B30-F6CCEEB333BCQ39007521-19A3405B-EFA7-4020-BA44-A092A8649B5AQ39387113-41D20135-4730-4D9B-8D8C-BC207506A0BBQ40511957-50688C3B-58B5-4685-A823-B9DF1AD55FA5Q43524452-B913BE17-F90B-4877-BA44-3D2EBE747985Q47125977-4CB0FAB9-4BF3-47F3-9349-53C55C57AD43Q50277167-129BCC5C-7465-4DA3-80CE-00390C6AD2F9
P2860
Hyponatremia in cirrhosis and end-stage liver disease: treatment with the vasopressin V₂-receptor antagonist tolvaptan.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Hyponatremia in cirrhosis and ...... receptor antagonist tolvaptan.
@ast
Hyponatremia in cirrhosis and ...... receptor antagonist tolvaptan.
@en
type
label
Hyponatremia in cirrhosis and ...... receptor antagonist tolvaptan.
@ast
Hyponatremia in cirrhosis and ...... receptor antagonist tolvaptan.
@en
prefLabel
Hyponatremia in cirrhosis and ...... receptor antagonist tolvaptan.
@ast
Hyponatremia in cirrhosis and ...... receptor antagonist tolvaptan.
@en
P2093
P2860
P921
P1476
Hyponatremia in cirrhosis and ...... receptor antagonist tolvaptan.
@en
P2093
Joseph Chiodo
Kwaku Marfo
Paul Gaglio
P2860
P2888
P304
P356
10.1007/S10620-012-2276-3
P577
2012-06-26T00:00:00Z
2012-11-01T00:00:00Z